Latest Capital Equipment News

Page 1 of 6
Imricor Medical Systems (ASX:IMR) has moved from regulatory preparation into US commercial deployment, signing its first two NorthStar hospital customers within weeks of launch. The milestone comes with sharply higher quarterly revenue, a fresh Philips pathway and a still-heavy cash burn.
Victor Sage
Victor Sage
13 Nov 2026
Amaero’s revenue surged 170% to US$11.5 million in the first nine months of 2026, but the advanced materials company still reported widening losses, heavy cash burn and substantial doubt about its ability to continue as a going concern. The newly Nasdaq-listed group expects fourth-quarter revenue of US$4.5 million to US$5.0 million, while warning that further funding will be needed.
Victor Sage
Victor Sage
10 Nov 2026
STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.
Ada Torres
Ada Torres
5 Nov 2026
Coherent delivered US$2.37 billion in fiscal first-quarter revenue and raised its fiscal 2027 pro forma growth outlook above 60%, helped by a sharp increase in datacentre and communications demand. The photonics company also flagged a five-year PhotonLink agreement valued at about US$20 billion, although meaningful revenue from that deal is not expected until early calendar 2028.
Sophie Babbage
Sophie Babbage
5 Nov 2026
Electrovaya will invest approximately A$2.0 million in Janus Electric through a proposed placement, while Janus has placed initial battery orders worth about A$37.5 million for its North American truck programme. The investment remains subject to completion conditions, and the battery orders depend on agreed delivery schedules.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Janus Electric has secured a repeat A$3.1 million order from California operator King Fio Trucking, lifting its North American order book to 124 trucks. The expansion reuses existing charging and battery-swapping infrastructure, but remains conditional on California incentive approval.
Victor Sage
Victor Sage
27 Oct 2026
Janus Electric has signed a non-binding MOU with ConGlobal for a proposed 20-truck Class 8 conversion pilot in Texas. A successful pilot could open a pathway to conversion, battery-swapping and servicing operations across ConGlobal’s 31 US depots, although no binding orders or commercial terms have been agreed.
Victor Sage
Victor Sage
26 Oct 2026
Janus Electric has secured A$11 million in Commonwealth Bank facilities to fund working capital, equipment and production expansion as it prepares to deliver its 118-truck North American order book. The first US conversions are scheduled for 2Q FY2, subject to applicable conditions.
Victor Sage
Victor Sage
23 Oct 2026
XRF Scientific has delivered its strongest September quarter in years, with revenue rising 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. Orbis growth, resilient consumables demand and the developing CGA business are giving the company several avenues for further expansion, although precious metals revenue included a low-margin one-off sale.
Victor Sage
Victor Sage
13 Oct 2026
Trajan Scientific and Medical (ASX:TRJ) says FY27 has begun with improving revenue, quarterly nEBITDA of about A$3.5 million and a A$1.6 million reduction in net debt. The company expects mid-single-digit organic revenue growth and double-digit nEBITDA growth for the year, although its latest quarterly figures remain unaudited.
Victor Sage
Victor Sage
8 Oct 2026
CONNEQT Health delivered sharp FY26 revenue growth and reduced its statutory loss as Pulse sales and clinical subscriptions expanded. But the ASX-listed medtech group ended the year with negative net assets, heavy cash burn and a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.
Victor Sage
Victor Sage
30 Sept 2026

Browse the archive

Full archive